- Home
- QNCX vs LFT Comparison
QNCX vs LFT Comparison
Compare QNCX & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- LFT
- Stock Information
- Founded
- QNCX 2012
- LFT 2012
- Country
- QNCX United States
- LFT United States
- Employees
- QNCX N/A
- LFT N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- LFT Real Estate Investment Trusts
- Sector
- QNCX Health Care
- LFT Real Estate
- Exchange
- QNCX Nasdaq
- LFT Nasdaq
- Market Cap
- QNCX 88.6M
- LFT 82.2M
- IPO Year
- QNCX 2019
- LFT N/A
- Fundamental
- Price
- QNCX $1.60
- LFT $1.54
- Analyst Decision
- QNCX Strong Buy
- LFT Hold
- Analyst Count
- QNCX 6
- LFT 1
- Target Price
- QNCX $8.00
- LFT N/A
- AVG Volume (30 Days)
- QNCX 271.4K
- LFT 184.1K
- Earning Date
- QNCX 11-12-2025
- LFT 11-07-2025
- Dividend Yield
- QNCX N/A
- LFT 15.48%
- EPS Growth
- QNCX N/A
- LFT N/A
- EPS
- QNCX N/A
- LFT 0.18
- Revenue
- QNCX N/A
- LFT $25,803,999.00
- Revenue This Year
- QNCX N/A
- LFT $124.75
- Revenue Next Year
- QNCX N/A
- LFT N/A
- P/E Ratio
- QNCX N/A
- LFT $8.61
- Revenue Growth
- QNCX N/A
- LFT N/A
- 52 Week Low
- QNCX $0.72
- LFT $1.50
- 52 Week High
- QNCX $2.45
- LFT $2.84
- Technical
- Relative Strength Index (RSI)
- QNCX 37.36
- LFT 20.23
- Support Level
- QNCX $1.76
- LFT $1.50
- Resistance Level
- QNCX $1.88
- LFT $1.75
- Average True Range (ATR)
- QNCX 0.10
- LFT 0.07
- MACD
- QNCX -0.03
- LFT -0.01
- Stochastic Oscillator
- QNCX 9.28
- LFT 12.00
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.